These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39242444)

  • 1. High-quality identification of volatile organic compounds (VOCs) originating from breath.
    Arulvasan W; Chou H; Greenwood J; Ball ML; Birch O; Coplowe S; Gordon P; Ratiu A; Lam E; Hatch A; Szkatulska M; Levett S; Mead E; Charlton-Peel C; Nicholson-Scott L; Swann S; van Schooten FJ; Boyle B; Allsworth M
    Metabolomics; 2024 Sep; 20(5):102. PubMed ID: 39242444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
    Suzukawa M; Ohta K; Sugimoto M; Ohshima N; Kobayashi N; Tashimo H; Tanimoto Y; Itano J; Kimura G; Takata S; Nakano T; Yamashita T; Ikegame S; Hyodo K; Abe M; Chibana K; Kamide Y; Sasaki K; Hashimoto H
    Allergol Int; 2024 Oct; 73(4):524-531. PubMed ID: 38658257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical research.
    Lamy E; Roquencourt C; Zhou B; Salvator H; Moine P; Annane D; Devillier P; Bardin E; Grassin-Delyle S
    Anal Bioanal Chem; 2024 Sep; 416(22):4929-4939. PubMed ID: 38980330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying exhaled acetone and isoprene through solid phase microextraction and gas chromatography-mass spectrometry.
    Schulz E; Woollam M; Vashistha S; Agarwal M
    Anal Chim Acta; 2024 May; 1301():342468. PubMed ID: 38553125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile Organic Compounds in Human Breath.
    Karunagaran M; Ramani P; Gheena S; Abilasha R; Hannah R
    Indian J Dent Res; 2022; 33(1):100-104. PubMed ID: 35946254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of breath sample collection method and length of storage of breath samples in Tedlar bags on the level of selected volatiles assessed using gas chromatography-ion mobility spectrometry (GC-IMS).
    Czippelová B; Nováková S; Šarlinová M; Baranovičová E; Urbanová A; Turianiková Z; Krohová JČ; Halašová E; Škovierová H
    J Breath Res; 2024 May; 18(3):. PubMed ID: 38701772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peppermint breath test: a benchmarking protocol for breath sampling and analysis using GC-MS.
    Wilkinson M; White I; Hamshere K; Holz O; Schuchardt S; Bellagambi FG; Lomonaco T; Biagini D; Di FF; Fowler SJ
    J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33302258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath analysis for the discrimination of asthma and chronic obstructive pulmonary disease.
    Li L; Chen H; Shi J; Chai S; Yan L; Meng D; Cai Z; Guan J; Xin Y; Zhang X; Sun W; Lu X; He M; Li Q; Yan X
    J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38834048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic insights at the finish line: deciphering physiological changes in ultramarathon runners through breath VOC analysis.
    Chou H; Arthur K; Shaw E; Schaber C; Boyle B; Allsworth M; Kelley EF; Stewart GM; Wheatley CM; Schwartz J; Fermoyle CC; Ziegler BL; Johnson KA; Robach P; Basset P; Johnson BD
    J Breath Res; 2024 Feb; 18(2):. PubMed ID: 38290132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.
    Chou H; Godbeer L; Allsworth M; Boyle B; Ball ML
    Metabolomics; 2024 Jul; 20(4):72. PubMed ID: 38977623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.